SALUS DISCOVERY LLC

Madison, WI · Medtech · Private

Point-of-care immunoassay for detecting circulating anodic antigen (CAA) in urine to diagnose schistosomiasis infections

salusd.com →
Grants
$12M
21 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$299K
1 award · Health and Human S
#424 of 4531 in medtech
Patents
19
6 granted · 13 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Getting More from Less: Multi-omic Capture and Analysis from Patient Samples$240,747
Federal contractDepartment of Health and Human Services · Igf::ot::igf The Microvoa: Enhancing The Viral Outgrowth Assay (voa) With Microtechnology$298,743
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · Seeing the unseen: Enhancing purification of labile protein complexes and cells with low surface marker expression$700,000
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Seeing the unseen: Enhancing purification of labile protein complexes and cells with low surface marker expression$350,000
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase II · Getting More from Less: Multi-omic Capture and Analysis from Patient Samples$1,068,815
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase II · Getting More from Less: Multi-omic Capture and Analysis from Patient Samples$535,014
Federal grantDepartment of Health and Human Services · Phase I · Development of a cell based assay to assess antigen specific tolerance$225,000
Federal grantDepartment of Health and Human Services · Phase I · Development of a cell based assay to assess antigen specific tolerance$225,000
Federal grantDepartment of Health and Human Services · Phase II · Getting More from Less: Multi-omic Capture and Analysis from Patient Samples$533,801
Federal grantDepartment of Health and Human Services · Phase I · Seeing the unseen: Enhancing purification of labile protein complexes and cells with low surface marker expression$350,000
Federal grantDepartment of Health and Human Services · Phase II · Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology$436,366
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase II · Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology$962,850
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase II · Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology$962,850
Federal grantDepartment of Health and Human Services · Phase I · Enhancing detection and mobile monitoring of schistosomiasis with urine-based analyte pre-concentration technology$275,526
Federal grantDepartment of Health and Human Services · Phase I · Enhancing detection and mobile monitoring of schistosomiasis with urine-based analyte pre-concentration technology$275,526
Federal grantDepartment of Health and Human Services · Phase II · Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology$818,507
Federal grantDepartment of Health and Human Services · Phase I · 3STEP: A swab-seal-read, point-of-care nucleic acid test to address disparity in STI screening and prevention$275,736
Federal grantDepartment of Health and Human Services · Phase II · 3STEP: A swab-seal-read assay for tuberculosis and RIF resistance enabled by autonomous extraction technology$295,893
Federal grantDepartment of Health and Human Services · Phase II · Flow Direct: Next Generation Urine LFA for TB Diagnosis in Point-of-Care Settings$300,000
Federal grantDepartment of Health and Human Services · Phase II · 3STEP: A swab-seal-read assay for tuberculosis and RIF resistance enabled by autonomous extraction technology$1,000,000
Federal grantDepartment of Health and Human Services · Phase II · Flow Direct: Next Generation Urine LFA for TB Diagnosis in Point-of-Care Settings$916,195
Federal grantDepartment of Health and Human Services · Phase II · 3STEP: A swab-seal-read assay for tuberculosis and RIF resistance enabled by autonomous extraction technology$913,705
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
421ESPER BIOSCIENCES INC$300K—
422DARWIN BIOSCIENCES, INC.$299K—
423SEVIDENT, INC.$299K—
424SALUS DISCOVERY LLC$299K—
425Focal Medical, Inc.$298K$6.4M
426MGENUITY CORPORATION$296K—
427Koronis Biomedical Technologies Corp.$296K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 6 granted of 19

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.